Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Why Don't We All Get… >
Why Don't We All Get Alzheimer's Disease?

Published: August 7, 2013.
By University of California - San Diego
http://www.ucsd.edu

Though one might think the brains of people who develop Alzheimer's disease (AD) possess building blocks of the disease absent in healthy brains, for most sufferers, this is not true. Every human brain contains the ingredients necessary to spark AD, but while an estimated 5 million Americans have AD – a number projected to triple by 2050 – the vast majority of people do not and will not develop the devastating neurological condition.

For researchers like Subhojit Roy, MD, PhD, associate professor in the Departments of Pathology and Neurosciences at the University of California, San Diego School of Medicine, these facts produce a singular question: Why don't we all get Alzheimer's disease?

In a paper published in the August 7 issue of the journal Neuron, Roy and colleagues offer an explanation – a trick of nature that, in most people, maintains critical separation between a protein and an enzyme that, when combined, trigger the progressive cell degeneration and death characteristic of AD.

"It's like physically separating gunpowder and match so that the inevitable explosion is avoided," said principal investigator Roy, a cell biologist and neuropathologist in the Shiley-Marcos Alzheimer's Disease Research Center at UC San Diego. "Knowing how the gunpowder and match are separated may give us new insights into possibly stopping the disease."

The severity of AD is measured in the loss of functioning neurons. In pathological terms, there are two tell-tale signs of AD: clumps of a protein called beta-amyloid "plaques" that accumulate outside neurons and threads or "tangles" of another protein, called tau, found inside neurons. Most neuroscientists believe AD is caused by the accumulating assemblies of beta-amyloid protein triggering a sequence of events that leads to impaired cell function and death. This so-called "amyloid cascade hypothesis" puts beta-amyloid protein at the center of AD pathology.

Creating beta-amyloid requires the convergence of a protein called amyloid precursor protein (APP) and an enzyme that cleaves APP into smaller toxic fragments called beta-secretase or BACE.

"Both of these proteins are highly expressed in the brain," said Roy, "and if they were allowed to combine continuously, we would all have AD."

But that doesn't happen. Using cultured hippocampal neurons and tissue from human and mouse brains, Roy – along with first author Utpal Das, a postdoctoral fellow in Roy's lab, and colleagues – discovered that healthy brain cells largely segregate APP and BACE-1 into distinct compartments as soon as they are manufactured, ensuring the two proteins do not have much contact with each other.

"Nature seems to have come up with an interesting trick to separate co-conspirators," said Roy.

The scientists also found that the conditions promoting greater production of beta-amyloid protein boost the convergence of APP and BACE. Specifically, an increase in neuronal electrical activity – known to increase the production of beta-amyloid – also led to an increase in APP-BACE convergence. Post-mortem examinations of AD patients revealed increased physical proximity of the proteins as well, adding support to the pathophysiological significance of this phenomenon in human disease.

Das said the findings are fundamentally important because they elucidate some of the earliest molecular events triggering AD and show how a healthy brain naturally avoids them. In clinical terms, they point to a possible new avenue for ultimately treating or even preventing the disease.

"An exciting aspect is that we can perhaps screen for molecules that can physically keep APP and BACE-1 apart," said Das. "It's a somewhat unconventional approach."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


 
All comments are reviewed before being posted. We cannot accept messages that refer a product, or web site.If you are looking for a response to a question please use our another feedback page.
Related »

Rosenberg 
10/8/10 
UT Southwestern Researchers Create Experimental Vaccine Against Alzheimer's
By UT Southwestern Medical Center
DALLAS – Oct. 12, 2010 – Researchers at UT Southwestern Medical Center have created an experimental vaccine against beta-amyloid, the small protein that forms plaques in the brain and …
Toxic 
5/3/12 
★★ 
Scientists Gain New Understanding of Alzheimer's Trigger
By University of Virginia
May 2, 2012 — A highly toxic beta-amyloid – a protein that exists in the brains of Alzheimer's disease victims – has been found to greatly increase the toxicity …
Cells 
4/11/13 
New Findings on the Brain's Immune Cells During Alzheimer's Disease Progression
By Helmholtz Association of German Research Centres
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one …
Cd33 
4/25/13 
Suppressing Protein May Stem Alzheimer's Disease Process
By National Institute of Mental Health
Scientists funded by the National Institutes of Health have discovered a potential strategy for developing treatments to stem the disease process in Alzheimer's disease. It's based on unclogging removal …
Microglia 
4/25/13 
New Insights into Alzheimer's Gene Paves the Way for Prevention
By Cell Press
Alzheimer's disease is the most common neurodegenerative disorder, affecting more than five million Americans, but currently there is no way to prevent, delay or stop its progression. A study …
Alzheimer 
12/13/13 
Study Breaks Blood-brain Barriers to Understanding Alzheimer's
By National Institute of Neurological Disorders and Stroke
A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest …
Immune 
2/3/14 
Can a Protein Controlling Blood Pressure Enhance Immune Responses And Prevent Alzheimer's?
By Cedars-Sinai Medical Center
LOS ANGELES (EMBARGOED UNTIL 12 NOON EST ON FEB. 3, 2014) – Many people with high blood pressure are familiar with ACE inhibitors, drugs that widen blood vessels by …
Mayo 
9/17/12 
Mayo Clinic Researchers Identify New Enzyme to Fight Alzheimer's Disease
By Mayo Clinic
JACKSONVILLE, Fla. — An enzyme that could represent a powerful new tool for combating Alzheimer's disease has been discovered by researchers at Mayo Clinic in Florida. The enzyme — …
Proteins 
10/24/13 
Study by Researchers at Saarland University Demonstrates Preventive Effect of Sterols in Alzheimer's
By Saarland University
"Plant sterols are present in various combinations in nuts, seeds and plant oils. As plant sterols are the equivalents of animal cholesterol, they can in principal influence metabolic processes, …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese Edition